Development of Recombinant Immunotoxins for Hairy Cell Leukemia

Hairy cell leukemia (HCL) is an indolent B-cell malignancy with excellent initial response to purine analogs pentostatin or cladribine, but patients are rarely, if ever, cured. Younger patients will usually need repeat chemotherapy which has declining benefits and increasing toxicities with each cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreitman, Robert J., Pastan, Ira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464581/
https://www.ncbi.nlm.nih.gov/pubmed/32756468
http://dx.doi.org/10.3390/biom10081140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464581/
https://www.ncbi.nlm.nih.gov/pubmed/32756468
http://dx.doi.org/10.3390/biom10081140

Ejemplares similares